Global RNA Sequencing Services Market Report 2022 with Profiles of Admera Health, Biogazelle, CD Genomics, Creative Biogene, IGA Technology, LC Sciences, Lexogen, Novogene, Otogenetics, Yaazh Xenomic
Thursday, December 15, 2022
DUBLIN, Dec. 7, 2022 /PRNewswire/ -- The "RNA Sequencing Services Market: Distribution by Type of Sequencing Method, Application Area, End User Industry and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035" report has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
The 'RNA Sequencing Services Market'' report features an extensive study of the current market landscape and future potential of the RNA sequencing services market. The study also includes an in-depth analysis, highlighting the capabilities of RNA sequencing service providers.
One of the key objectives of the report was to estimate the current market size and the future potential associated with the RNA sequencing services market, over the coming 13 years. We have provided informed estimates of the likely evolution of the market in the short to mid-term and long term, for the period 2022-2035.
Among various sequencing methods, next generation sequencing (NGS) introduced by Lynx Therapeutics in 2000, has emerged as a preferred choice across the industry. It is a high throughput, parallel genome sequencing technology, which enables whole genome and whole exome sequencing. It enables reduction in overall cost and process time.
Despite the various technological advancements in RNA sequencing, there are several existing challenges, including difficulty in sequencing of large genes, shortage of human resources and lack of tools for data manipulation and analysis.
In addition, establishment and maintenance of next generation sequencing based facilities require high capital. In order to overcome these challenges and obtain a high-quality output, the outsourcing of RNA sequencing is considered as a preferable option, among other alternatives, by industry players.
Currently, more than 70 companies offer services related to RNA sequencing. A number of these companies are start-ups that have been established in the past decade. In addition, several stakeholders are engaged in the development of proprietary technologies in order to overcome the errors related to amplification and duplication rates while sequencing.
Further, over 340 patents related to RNA sequencing have been recently filed / granted, which demonstrates the innovation and continuous research efforts in this domain. Moreover, over the last few years, grants worth USD 486 million have been awarded by National Institutes of Health to support the ongoing R&D efforts in this domain.
Driven by the growing interest of various stakeholders and the wide applicability of this technique, we believe that the RNA sequencing services industry is anticipated to witness noteworthy growth in the foreseen future.
Amongst other elements, the report features:
-- A general overview of RNA sequencing, along with information on the key
steps involved in the process, details on the various types, methods and
applications of RNA sequencing, as well as the advantages and
limitations associated with RNA sequencing. It further includes details
on the different types of RNA sequencing platforms.
-- A detailed overview of the market landscape of RNA sequencing service
providers, based on several relevant parameters, such as their year of
establishment, company size (in terms of number of employees), region of
headquarters (North America, Europe, Asia-Pacific and MENA). In
addition, the chapter features information on the various offerings of
such service providers, including type of RNA sequencing service(s),
type of platform (Illumina, PacBio, Nanopore and others), turnaround
time, type of sample (human, animal, plant, microorganisms and others)
and volume of sample.
-- A competitiveness analysis of RNA sequencing service providers, located
in North America, Europe, and Asia Pacific and Rest of the World. The
analysis compares service providers on the basis of various relevant
parameters, such as experience of the company (in terms of number of
years since it was established), service portfolio strength (in terms of
number of RNA sequencing services offered, number of samples and
turnaround time) and platform diversity (in terms of number of RNA
sequencing services offered via respective sequencing platforms).
-- Elaborate profiles of key players involved in providing services for RNA
sequencing. Each profile features a brief overview of the company,
details on its service portfolio and recent developments, along with an
informed future outlook.
-- An in-depth analysis of grants awarded to various research institutes
for projects related to RNA sequencing, since 2018, based on several
relevant parameters, such as year of grant awarded, amount awarded,
administering institute center, support period, type of grant
application, purpose of grant, activity code, study section, type of
organization, emerging focus areas, popular NIH departments, popular
recipient organizations (in terms of number of grants and amount
awarded), prominent program officers and location of recipient
organizations.
-- An insightful analysis of patents filed / granted for RNA sequencing,
since 2018, taking into consideration various relevant parameters, such
as type of patent, publication year, application year, geographical
location, CPC symbols, emerging focus areas, type of applicant, leading
players and individual assignees (in terms of number of patents granted
/ filed in the given time period). In addition, the chapter includes a
detailed patent benchmarking and an insightful valuation analysis,
highlighting the leading patents (in terms of number of citations).
-- A qualitative analysis of the five competitive forces, including threats
of new entrants, bargaining power of customers, bargaining power of RNA
sequencing service providers, threats of substitute services and rivalry
among existing competitors under an insightful Porter's Five Forces
framework.
-- A case study on NGS library preparation kits, based on type of platform,
amount of sample, turnaround time, storage temperature, type of
sequencing(s), kit components, type of sample. In addition, it includes
a study on NGS library preparation kit developers, featuring analyses
based on their year of establishment, company size and geographical
presence.
-- An insightful analysis, highlighting financial attributes (payback
period, total cash inflow, and earning potential of platforms) that need
to be taken into consideration by various RNA sequencing service
providers to facilitate decision making to employ sequencing platform.
Key Questions Answered
-- Who are the key players engaged in offering RNA sequencing services?
-- What is the average turnaround time of RNA sequencing services currently
offered?
-- What is the relative competitiveness of different RNA sequencing service
providers?
-- How has the intellectual property landscape of RNA sequencing evolved
over the years?
-- Which are the leading funding institutes / centers supporting research
related to RNA sequencing?
-- Which type of next generation sequencing kits are being used to collect
samples for RNA sequencing?
-- Which sequencing platform is likely to offer highest earning potential
to service providers?
-- How is the current and future market opportunity likely to be
distributed across key market segments?
Key Topics Covered:
1. PREFACE
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. An Overview of RNA Sequencing
3.3. Concluding Remarks
4. RNA SEQUENCING SERVICE PROVIDERS: MARKET OVERVIEW
4.1. Chapter Overview
4.1.1. RNA Sequencing Service Providers
4.1.2. Analysis by Year of Establishment
4.1.3. Analysis by Company Size
4.1.4. Analysis by Location of Headquarters
4.1.5. Analysis by Company Size and Region of Headquarters
4.1.6. Analysis by Type of RNA Sequencing Service(s)
4.1.7. Analysis by Type of Platform
4.1.8. Analysis by Turnaround Time
4.1.9. Analysis by Type of Sample
4.1.10. Analysis by Amount of Sample
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Scope and Methodology
5.4. Company Competitiveness Analysis: RNA Sequencing Service Providers in North America
5.5. Company Competitiveness Analysis: RNA Sequencing Service Providers in Europe
5.6. Company Competitiveness Analysis: RNA Sequencing Service Providers in Asia-Pacific and Rest of the World
6. COMPANY PROFILES
6.1. Chapter Overview
6.2. Admera Health
6.2.1. Company Overview
6.2.2. RNA Sequencing Service Portfolio
6.2.3. Recent Developments and Future Outlook
6.3. Biogazelle (acquired by CellCarta)
6.4. CD Genomics
6.5. Creative Biogene
6.6. IGA Technology
6.7. LC Sciences
6.8. Lexogen
6.9. Novogene
6.10. Otogenetics
6.11. Yaazh Xenomic
7. ACADEMIC GRANT ANALYSIS
7.1. Chapter Overview
7.2. Scope and Methodology
7.3. Analysis by Year of Grant Award
8. PATENT ANALYSIS
8.1. Chapter Overview
8.2. Scope and Methodology
8.3. RNA Sequencing: Patent Analysis
8.4. RNA Sequencing: Patent Benchmarking Analysis
8.5. RNA sequencing: Patent Valuation Analysis
8.6. Leading Patents: Analysis by Number of Citations
9. PORTER'S FIVE FORCES ANALYSIS
9.1. Chapter Overview
9.2. Methodology and Assumptions
9.3. Key Parameters
9.4. Concluding Remarks
10. CASE STUDY: NGS LIBRARY PREPARATION KITS
10.1. Chapter Overview
10.2. NGS Library Preparation Kits: Overall Market Landscape
10.3. NGS Library Preparation Kits: Developer Landscape
11. INVESTMENT POTENTIAL ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Profit Potential of Commonly used RNA Sequencing Platforms
11.4. Payback Evaluation Matrix
11.3. Conclusion
12. MARKET SIZING AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Forecast Methodology and Key Assumptions
12.3. Global RNA Sequencing Services Market, 2022-2035
13. EXECUTIVE INSIGHTS
14. APPENDIX 1: TABULATED DATA
15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
-- Abclonal
-- Active Motif
-- Admera Health
-- Agendia
-- Agilent Technologies
-- AgriGenome Labs
-- Allen Institute
-- Almac
-- Applied Biological Materials
-- Arraystar
-- Australian Genome Research Facility (AGRF)
-- Back Bay Life Science Advisors
-- BaseClear
-- BGI
-- Bioarray Genetics
-- BioCat
-- BioChain
-- BioDynami
-- Biogazelle (acquired by CellCarta)
-- Biokart India
-- Bioneer
-- Bio-Rad
-- Bioserve Biotechnologies (a subsidiary of Reprocell Company)
-- Brigham and Women's Hospital
-- C2i Genomics
-- CD Genomics
-- CeGaT
-- Celemics
-- Cellecta
-- Clevergene Biocorp
-- Columbia University Health Sciences
-- Creative Biogene
-- Creative Biolabs
-- Creative BioMart
-- CureVac
-- DiaCarta
-- Diagenode (acquired by Hologic)
-- Diagnomics
-- DNA Link
-- DNAVision
-- Duke Center for Genomic and Computational Biology
-- Eclipse Bioinnovations
-- Enzo Life Sciences
-- Eremid Research Services
-- Eurofins Genomics
-- Fasteris
-- Firalis
-- Fluidigm
-- Frontage Laboratories
-- Garvan Institute of Medical Research
-- GB HealthWatch
-- GCC Biotech
-- GENEWIZ (acquired by Azenta Life Sciences)
-- Genome Quebec
-- GenomeScan
-- Genome Technology Access Center (a part of Washington University)
-- Genomix4Life
-- Genotypic Technology
-- GenXPro
-- Grail
-- Harvard Medical School
-- Icahn School of Medicine
-- IGA Technology Services
-- Illumina
-- IntegraGen (acquired by OncoDNA)
-- Integrated DNA Technologies
-- Isogen Life Science
-- Johns Hopkins University
-- Koninklijke Philips
-- LC Sciences
-- Lexogen
-- Loop Genomics
-- Macrogen
-- Massachusetts General Hospital
-- Massachusetts Institute of Technology (MIT)
-- Mayo Clinic
-- MedGenome
-- Memorial Sloan Kettering Cancer Center
-- Messenger Biopharma
-- MGI
-- Microsynth
-- Molecular Research (MR DNA)
-- myGenomics
-- New England Biolabs (NEB)
-- Norgen Biotek
-- Novogene
-- Nucleome Informatics
-- Omega Bioservices
-- Otogenetics
-- Oxford Nanopore Technologies
-- Pacific Biosciences (PacBio)
-- PerkinElmer
-- PhalanxBio (a subsidiary of Phalanx Biotech)
-- Psomagen
-- Q2 Solutions
-- QIAGEN
-- Quick Biology
-- RealSeq Biosciences
-- RefGen Biotechnology
-- RNA Society
-- Roche
-- SeqMatic
-- Source BioScience
-- SRM Institute of Science and Technology
-- Stanford University
-- Swift Biosciences (acquired by Integrated DNA Technologies)
-- System Biosciences (SBI)
-- Takara Bio
-- TAmiRNA
-- Tecan
-- Thermo Fisher Scientific
-- TIANGEN Biotech
-- TriLink BioTechnologies
-- Ultima Genomics
-- University of California
-- University of Pennsylvania
-- Vazyme Biotech
-- Xcelris Genomics
-- Yaazh Xenomics
-- Yale University
-- YouSeq
-- Zymo Research
For more information about this report visit https://www.researchandmarkets.com/r/kkn9q9
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/global-rna-sequencing-services-market-report-2022-with-profiles-of-admera-health-biogazelle-cd-genomics-creative-biogene-iga-technology-lc-sciences-lexogen-novogene-otogenetics-yaazh-xenomic-301697028.html
SOURCE Research and Markets
|
|
|
|
|
 |
Sup AI Sets New Benchmark Record with 52.15% on Humanity's Last Exam | Jan 22, 2026
|
|
Skunk Works® and XTEND Expand Joint All Domain Command and Control for Advanced Mission Execution | Jan 22, 2026
|
|
Weekly Recap: 11 Tech Press Releases You Need to See | Jan 22, 2026
|
|
DEADLINE ANNOUNCED FOR 2026 NEW TOP-LEVEL DOMAIN APPLICATIONS | Jan 22, 2026
|
|
Trigent Partners with WeWork India to Expand its GCC Footprint | Jan 22, 2026
|
|
Glasswall Brings Defense-Level File Sanitization to Every Government Agency and Business Using Microsoft 365 | Jan 22, 2026
|
|
Genpact Named a Leader in ISG Provider Lens(TM) 2025 for Insurance GCCs and Agentic AI Services | Jan 22, 2026
|
|
Altair HyperWorks 2026 Delivers Design and Simulation at Scale with AI | Jan 22, 2026
|
|
Exia Labs Brings Keystone to the U.S. Navy via DIU's Blue Object Management Challenge | Jan 22, 2026
|
|
Buyers Edge Platform Appoints Jaime Selga to Lead Expansion Across the Middle East, Africa & Asia | Jan 22, 2026
|
|
|
